Single Patent for EU

After decades of political wrangling, the European Union is poised to introduce a single patent system to reduce red tape and application costs for researchers and companies.

Written byDan Cossins
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WikimediaThe European Union (EU) looks set to introduce a unified patent system in 2014 after the European Parliament this week (December 11) voted in favor of the change. If ratified, the new system will provide uniform legal protection across 25 European countries with a single patent and reduce application costs and paperwork in the hope of making Europe more competitive in innovation-led industries like biotechnology.

At the moment, researchers and companies seeking protection for their inventions in Europe are forced to apply separately to 27 different jurisdictions in 23 different languages. A single patent system was first proposed in 1973, but the idea got stuck in a political quagmire as member states fought over the details.

The proposed system would make the process far simpler, cutting down on red tape and reducing the price tag for applicants. According to the EU, the costs of a Europe-wide patent would fall from the current rate of around €36,000 ($47,000) to €6,400 ($8,500). Although that’s still notably higher than the $2,390 required for a US patent, EU leaders hope that the reduced costs will help Europe catch up with its global competitors in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies